KR102928543B1 - 골드 키위 조성물과 준비 방법 및 그 사용 - Google Patents

골드 키위 조성물과 준비 방법 및 그 사용

Info

Publication number
KR102928543B1
KR102928543B1 KR1020237037806A KR20237037806A KR102928543B1 KR 102928543 B1 KR102928543 B1 KR 102928543B1 KR 1020237037806 A KR1020237037806 A KR 1020237037806A KR 20237037806 A KR20237037806 A KR 20237037806A KR 102928543 B1 KR102928543 B1 KR 102928543B1
Authority
KR
South Korea
Prior art keywords
composition
gold
kiwifruit
powder
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020237037806A
Other languages
English (en)
Korean (ko)
Other versions
KR20230156436A (ko
Inventor
줄리엣 안셀
폴 블라취포드
Original Assignee
아나제닉스 아이피 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아나제닉스 아이피 리미티드 filed Critical 아나제닉스 아이피 리미티드
Publication of KR20230156436A publication Critical patent/KR20230156436A/ko
Application granted granted Critical
Publication of KR102928543B1 publication Critical patent/KR102928543B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/01—Instant products; Powders; Flakes; Granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020237037806A 2014-11-28 2015-11-27 골드 키위 조성물과 준비 방법 및 그 사용 Active KR102928543B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
NZ702454 2014-11-28
NZ70245414 2014-11-28
NZ706405 2015-03-27
NZ70640515 2015-03-27
PCT/NZ2015/050200 WO2016085356A1 (en) 2014-11-28 2015-11-27 Gold kiwifruit compositions and methods of preparation and use therefor
KR1020177017760A KR102599549B1 (ko) 2014-11-28 2015-11-27 골드 키위 조성물과 준비 방법 및 그 사용

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020177017760A Division KR102599549B1 (ko) 2014-11-28 2015-11-27 골드 키위 조성물과 준비 방법 및 그 사용

Publications (2)

Publication Number Publication Date
KR20230156436A KR20230156436A (ko) 2023-11-14
KR102928543B1 true KR102928543B1 (ko) 2026-02-19

Family

ID=56074755

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020237037806A Active KR102928543B1 (ko) 2014-11-28 2015-11-27 골드 키위 조성물과 준비 방법 및 그 사용
KR1020177017760A Active KR102599549B1 (ko) 2014-11-28 2015-11-27 골드 키위 조성물과 준비 방법 및 그 사용

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020177017760A Active KR102599549B1 (ko) 2014-11-28 2015-11-27 골드 키위 조성물과 준비 방법 및 그 사용

Country Status (16)

Country Link
US (4) US10512663B2 (https=)
EP (2) EP4548775A3 (https=)
JP (3) JP7330667B2 (https=)
KR (2) KR102928543B1 (https=)
CN (3) CN106999523A (https=)
BR (1) BR112017011078B1 (https=)
CA (2) CA2967263A1 (https=)
DK (1) DK3223838T3 (https=)
ES (1) ES3023661T3 (https=)
FI (1) FI3223838T3 (https=)
MY (1) MY188290A (https=)
NZ (1) NZ732197A (https=)
PL (1) PL3223838T3 (https=)
PT (1) PT3223838T (https=)
SI (1) SI3223838T1 (https=)
WO (1) WO2016085356A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102928543B1 (ko) * 2014-11-28 2026-02-19 아나제닉스 아이피 리미티드 골드 키위 조성물과 준비 방법 및 그 사용
KR101833348B1 (ko) * 2016-12-26 2018-03-02 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 유방암 진단방법
KR101833503B1 (ko) * 2016-12-26 2018-03-05 주식회사 엠디헬스케어 만성폐쇄성폐질환자에서 세균 메타게놈 분석을 통한 폐암 진단방법
KR101940426B1 (ko) * 2016-12-28 2019-01-18 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 대장종양 진단 방법
KR101942197B1 (ko) * 2016-12-28 2019-01-24 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 전립선질환 진단 방법
US11413318B2 (en) * 2017-06-06 2022-08-16 Sami-Sabinsa Group Limited Compositions and methods for management of atrophic gastritis and colitis
US10881675B2 (en) 2017-10-11 2021-01-05 Jennifer L. Gu Gut health compositions
KR102130485B1 (ko) * 2017-10-13 2020-07-06 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 알츠하이머치매 진단방법
KR102007786B1 (ko) * 2017-10-18 2019-08-07 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 두경부암 진단방법
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
KR101940950B1 (ko) 2018-01-23 2019-01-21 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 담관암 진단방법
KR101944662B1 (ko) * 2018-02-14 2019-02-01 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 뇌졸중 진단방법
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CN109288104B (zh) * 2018-11-12 2023-09-01 方家铺子（莆田）绿色食品有限公司 一种桂圆鲜果挂黄处理设备及其处理方法
ES2884072T1 (es) 2019-01-18 2021-12-10 Cp Kelco Us Inc Composición prebiótica y su uso
CN110279814A (zh) * 2019-06-10 2019-09-27 湖北虹玮农业有限公司 一种用于中老年慢性便秘的功能食品
US11684645B2 (en) * 2019-11-26 2023-06-27 Tci Co., Ltd. Actinidia chinensis Planch ferment and use thereof
WO2022115709A2 (en) * 2020-11-30 2022-06-02 January, Inc. Methods and composition for treating metabolic syndrome
US12527515B2 (en) 2021-01-22 2026-01-20 Cilag Gmbh International Colorectal surgery post-surgical monitoring
US12569203B2 (en) * 2021-01-22 2026-03-10 Cilag Gmbh International Bariatric surgery post-surgical monitoring
US12543982B2 (en) 2021-01-22 2026-02-10 Cilag Gmbh International Method of adjusting a surgical parameter based on biomarker measurements
KR102543549B1 (ko) * 2021-01-26 2023-06-15 주식회사 다솔마임마케팅사업부 칼라만시 발포정 및 그 제조 방법
CN113521109A (zh) * 2021-06-28 2021-10-22 广州知易生物科技有限公司 解纤维素拟杆菌在预防和/或治疗炎症性肠病中的应用
US12343366B2 (en) * 2021-11-05 2025-07-01 Tci Co., Ltd. Prebiotic composition and method for improving intestinal health using the same
CN116076711A (zh) * 2021-11-05 2023-05-09 百岳特生物技术（上海）有限公司 益生质组合物及其用途
EP4436407A1 (en) 2021-11-22 2024-10-02 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
JP7701899B2 (ja) * 2022-09-14 2025-07-02 花王株式会社 クロロゲン酸類吸収量の予測方法
KR102536627B1 (ko) * 2022-09-30 2023-05-30 (주)바이텍 키위 발효물을 포함하는 알코올성 간손상 예방 또는 개선용 조성물
US20250195588A1 (en) * 2023-12-18 2025-06-19 First Day Life, Inc. Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics
US20250195594A1 (en) * 2023-12-18 2025-06-19 First Day Life Inc. Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics
US20250268957A1 (en) * 2024-02-22 2025-08-28 First Day Life, Inc. Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics
US20250302889A1 (en) * 2024-03-29 2025-10-02 First Day Life, Inc. Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics
NL2038369B1 (en) * 2024-07-31 2025-03-06 Sunbird Company Ltd A composition of natural kiwifruit powder and postbiotics and its use in constipation improvement

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100333243P1 (en) * 2009-06-30 2010-12-30 Lowe Russell G Kiwifruit variety named 'ZESY002'

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US22355A (en) 1858-12-21 sherwood
JP2750767B2 (ja) * 1990-02-21 1998-05-13 雪印乳業株式会社 新規糖アルコール
NZ235972A (en) 1990-11-06 1995-04-27 Amaranathan Balasingham Fruit product by soft pulping after skin removal
CN1107308A (zh) * 1994-02-25 1995-08-30 中国癌症研究基金会 猕猴桃天然营养口服液
JPH10313822A (ja) * 1997-05-20 1998-12-02 Pola Chem Ind Inc 腸内細菌叢改善剤及びそれを含有する組成物
AT503521A1 (de) 2006-05-05 2007-11-15 Omnica Gmbh Verwendung eines extraktes von kiwi-frucht
NZ554991A (en) * 2007-05-03 2009-11-27 Vital Food Processors Ltd Powdered kiwifruit extract compositions for the treatment of digestive dysfunction and/or gastrointestinal tract disorders
ES2437940T3 (es) * 2010-01-28 2014-01-15 Ab-Biotics S.A. Composición probiótica para uso en el tratamiento de la inflamación del intestino
KR102928543B1 (ko) * 2014-11-28 2026-02-19 아나제닉스 아이피 리미티드 골드 키위 조성물과 준비 방법 및 그 사용

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100333243P1 (en) * 2009-06-30 2010-12-30 Lowe Russell G Kiwifruit variety named 'ZESY002'

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Korean Journal of Plant Resources, 2011, 24(1), 61-68*

Also Published As

Publication number Publication date
BR112017011078B1 (pt) 2021-05-11
EP4548775A3 (en) 2025-08-27
FI3223838T8 (fi) 2025-06-16
EP4548775A2 (en) 2025-05-07
WO2016085356A1 (en) 2016-06-02
CA3200468A1 (en) 2016-06-02
US20200197460A1 (en) 2020-06-25
KR20170088970A (ko) 2017-08-02
PT3223838T (pt) 2025-04-28
KR20230156436A (ko) 2023-11-14
JP7330667B2 (ja) 2023-08-22
US20240091291A1 (en) 2024-03-21
JP2022078050A (ja) 2022-05-24
NZ732197A (en) 2022-07-01
US11642386B2 (en) 2023-05-09
BR112017011078A2 (pt) 2017-12-26
CN106999523A (zh) 2017-08-01
JP7471668B2 (ja) 2024-04-22
FI3223838T3 (fi) 2025-05-05
US20220105145A1 (en) 2022-04-07
EP3223838A4 (en) 2018-08-01
DK3223838T3 (da) 2025-04-28
US10512663B2 (en) 2019-12-24
SI3223838T1 (sl) 2025-07-31
NZ769769A (en) 2024-07-26
EP3223838B1 (en) 2025-02-05
US11090348B2 (en) 2021-08-17
ES3023661T3 (en) 2025-06-02
US20170326190A1 (en) 2017-11-16
JP2024088715A (ja) 2024-07-02
JP2017537156A (ja) 2017-12-14
CA2967263A1 (en) 2016-06-02
KR102599549B1 (ko) 2023-11-06
EP3223838A1 (en) 2017-10-04
CN116270773A (zh) 2023-06-23
PL3223838T3 (pl) 2025-05-26
MY188290A (en) 2021-11-25
CN116763830A (zh) 2023-09-19

Similar Documents

Publication Publication Date Title
JP7471668B2 (ja) ゴールドキウイフルーツ組成物ならびにその調製および使用方法
Paturi et al. Influence of dietary blueberry and broccoli on cecal microbiota activity and colon morphology in mdr1a−/− mice, a model of inflammatory bowel diseases
US10272122B2 (en) Lactobacillus plantarum inducia DSM 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against Clostridium difficile
Xiao et al. Lactic acid bacteria in health and disease
JP7360420B2 (ja) ディスバイオシスの治療のために用いられるブドウ果皮
US20240293483A1 (en) Probiotic composition for the treatment of increased intestinal permeability
KR20240099205A (ko) 장내 미생물군집 조절을 위한 프로바이오틱 조성물
US12194142B2 (en) Bacillus subtilis containing composition for treatment of gastrointestinal irregularity
SP Effects of Resveratrol in a Mouse Model of Alcohol Addiction
Braun Comparison of Bacterial Phylogenetic Diversity in Rat Fecal Pellets and Cecum & Probiotic and Blueberry Treatment Effects on Bacterial Community Composition

Legal Events

Date Code Title Description
A107 Divisional application of patent
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13 Administrative time limit extension granted

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T13-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13 Administrative time limit extension granted

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T13-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

E12 Pre-grant re-examination requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E12-REX-PX0901 (AS PROVIDED BY THE NATIONAL OFFICE)

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

F13 Ip right granted in full following pre-grant review

Free format text: ST27 STATUS EVENT CODE: A-3-4-F10-F13-REX-PX0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)